| Gaurav Jain, DO | |
|
13028 Monroe Manor Dr, Herndon, VA 20171-2997 | |
| (703) 899-5644 | |
| Not Available |
| Full Name | Gaurav Jain |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 13028 Monroe Manor Dr, Herndon, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336708205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0102207942 (Virginia) | Primary |
| Entity Name | Goyal Medpsych Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083260756 PECOS PAC ID: 3375978984 Enrollment ID: O20200108001378 |
News Archive
The advent of online social networks has led to the rapid development of tools for understanding the interactions between members of the network, their activity, the connections, the hubs and nodes. But, any relationships between lots of entities, whether users of Facebook and Twitter, bees in a colony, birds in a flock, or the genes and proteins in our bodies can be analyzed with the same tools.
Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients with advanced renal cell carcinoma (RCC).
Milwaukee Journal Sentinel: "Paula Oertel, whose brain tumor disappeared for nine years while she was on an expensive drug and returned after she temporarily lost her insurance coverage, has died as a result of the tumor spreading through her brain. The interruption of her Medicare coverage of the drug directly contributed to her death, contends her doctor, Mark Malkin, chief of neuro-oncology at Froedtert Hospital.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gaurav Jain, DO 13028 Monroe Manor Dr, Herndon, VA 20171-2997 Ph: (703) 899-5644 | Gaurav Jain, DO 13028 Monroe Manor Dr, Herndon, VA 20171-2997 Ph: (703) 899-5644 |
News Archive
The advent of online social networks has led to the rapid development of tools for understanding the interactions between members of the network, their activity, the connections, the hubs and nodes. But, any relationships between lots of entities, whether users of Facebook and Twitter, bees in a colony, birds in a flock, or the genes and proteins in our bodies can be analyzed with the same tools.
Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients with advanced renal cell carcinoma (RCC).
Milwaukee Journal Sentinel: "Paula Oertel, whose brain tumor disappeared for nine years while she was on an expensive drug and returned after she temporarily lost her insurance coverage, has died as a result of the tumor spreading through her brain. The interruption of her Medicare coverage of the drug directly contributed to her death, contends her doctor, Mark Malkin, chief of neuro-oncology at Froedtert Hospital.
› Verified 2 days ago
Dr. Susan Perlmutter, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 106 Elden St Ste 17, Herndon, VA 20170 Phone: 703-481-5214 | |
Dr. Rhea Nishita Mehra, M.D Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 489 Carlisle Dr Ste A, Herndon, VA 20170 Phone: 703-774-3234 Fax: 703-880-8414 | |
Churchill G Dunn Ii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 131 Elden St #150, Herndon, VA 20170 Phone: 703-402-4941 Fax: 703-430-9293 | |
Dr. Stephanie Ellen Waggel, MD, MS Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2201 Cooperative Way Ste 600, Herndon, VA 20171 Phone: 646-776-0739 Fax: 703-788-6867 | |
Dr. Caroline M. Tan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 297 Herndon Pkwy, Suite 202, Herndon, VA 20170 Phone: 571-323-3300 Fax: 571-323-3300 | |
Dr. Eric Robert Anderson, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2411 Dulles Corner Park Ste 475, Herndon, VA 20171 Phone: 800-762-9244 Fax: 786-672-6006 |